Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis

This study determines the value of linkage analysis using six RFLP markers for carrier detection and prenatal diagnosis in familial DMD/BMD cases and their family members for the first time in the Iranian population. We studied the dystrophin gene in 33 unrelated patients with clinical diagnosis of...

Full description

Bibliographic Details
Main Authors: Fardeen Ali Malayeri, Mojtaba Panjehpour, Ahmad Movahedian, Majid Ghaffarpour, Gholam Reza Zamani, Hajifaraj Tabrizi, Mahdi Zamani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2011-03-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/3712
id doaj-769be0f9ee8f46e78a4f31c14e0ed84e
record_format Article
spelling doaj-769be0f9ee8f46e78a4f31c14e0ed84e2020-11-25T02:50:30ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942011-03-01493Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage AnalysisFardeen Ali Malayeri0Mojtaba Panjehpour1Ahmad Movahedian2Majid Ghaffarpour3Gholam Reza Zamani4Hajifaraj Tabrizi5Mahdi Zamani6Department of Neurogenetics, Iranian Center of Neurological Research, Imam Khomeini Hospital , Tehran University of Medical Sciences, Tehran, Iran. AND Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.Iranian Center of Neurological Research, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.Department of Neurology, Children Medical Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Department of Neurogenetics, Iranian Center of Neurological Research, Imam Khomeini Hospital , Tehran University of Medical Sciences, Tehran, Iran. AND Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.This study determines the value of linkage analysis using six RFLP markers for carrier detection and prenatal diagnosis in familial DMD/BMD cases and their family members for the first time in the Iranian population. We studied the dystrophin gene in 33 unrelated patients with clinical diagnosis of DMD or BMD. Subsequently, we determined the rate of heterozygosity for six intragenic RFLP markers in the mothers of patients with dystrophin gene deletions. Finally, we studied the efficiency of linkage analysis by using RFLP markers for carrier status detection of DMD/BMD. In 63.6% of the patients we found one or more deletions. The most common heterozygous RFLP marker with 57.1% heterozygosity was pERT87.15Taq1. More than 80% of mothers in two groups of familial or non-familial cases had at least two heterozygous markers. Family linkage analysis was informative in more than 80% of the cases, allowing for accurate carrier detection. We found that linkage analysis using these six RFLP markers for carrier detection and prenatal diagnosis is a rapid, easy, reliable, and inexpensive method, suitable for most routine diagnostic services. The heterozygosity frequency of these markers is high enough in the Iranian population to allow carrier detection and prenatal diagnosis of DMD/BMD in more than 80% of familial cases in Iran. https://acta.tums.ac.ir/index.php/acta/article/view/3712Duchenne muscular dystrophyBecker muscular dystrophyDystrophin deletionsPolymerase chain reactionCarrier DetectionRFLP
collection DOAJ
language English
format Article
sources DOAJ
author Fardeen Ali Malayeri
Mojtaba Panjehpour
Ahmad Movahedian
Majid Ghaffarpour
Gholam Reza Zamani
Hajifaraj Tabrizi
Mahdi Zamani
spellingShingle Fardeen Ali Malayeri
Mojtaba Panjehpour
Ahmad Movahedian
Majid Ghaffarpour
Gholam Reza Zamani
Hajifaraj Tabrizi
Mahdi Zamani
Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis
Acta Medica Iranica
Duchenne muscular dystrophy
Becker muscular dystrophy
Dystrophin deletions
Polymerase chain reaction
Carrier Detection
RFLP
author_facet Fardeen Ali Malayeri
Mojtaba Panjehpour
Ahmad Movahedian
Majid Ghaffarpour
Gholam Reza Zamani
Hajifaraj Tabrizi
Mahdi Zamani
author_sort Fardeen Ali Malayeri
title Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis
title_short Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis
title_full Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis
title_fullStr Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis
title_full_unstemmed Detection of Duchenne/Becker Muscular Dystrophy Carriers in a Group of Iranian Families by Linkage Analysis
title_sort detection of duchenne/becker muscular dystrophy carriers in a group of iranian families by linkage analysis
publisher Tehran University of Medical Sciences
series Acta Medica Iranica
issn 0044-6025
1735-9694
publishDate 2011-03-01
description This study determines the value of linkage analysis using six RFLP markers for carrier detection and prenatal diagnosis in familial DMD/BMD cases and their family members for the first time in the Iranian population. We studied the dystrophin gene in 33 unrelated patients with clinical diagnosis of DMD or BMD. Subsequently, we determined the rate of heterozygosity for six intragenic RFLP markers in the mothers of patients with dystrophin gene deletions. Finally, we studied the efficiency of linkage analysis by using RFLP markers for carrier status detection of DMD/BMD. In 63.6% of the patients we found one or more deletions. The most common heterozygous RFLP marker with 57.1% heterozygosity was pERT87.15Taq1. More than 80% of mothers in two groups of familial or non-familial cases had at least two heterozygous markers. Family linkage analysis was informative in more than 80% of the cases, allowing for accurate carrier detection. We found that linkage analysis using these six RFLP markers for carrier detection and prenatal diagnosis is a rapid, easy, reliable, and inexpensive method, suitable for most routine diagnostic services. The heterozygosity frequency of these markers is high enough in the Iranian population to allow carrier detection and prenatal diagnosis of DMD/BMD in more than 80% of familial cases in Iran.
topic Duchenne muscular dystrophy
Becker muscular dystrophy
Dystrophin deletions
Polymerase chain reaction
Carrier Detection
RFLP
url https://acta.tums.ac.ir/index.php/acta/article/view/3712
work_keys_str_mv AT fardeenalimalayeri detectionofduchennebeckermusculardystrophycarriersinagroupofiranianfamiliesbylinkageanalysis
AT mojtabapanjehpour detectionofduchennebeckermusculardystrophycarriersinagroupofiranianfamiliesbylinkageanalysis
AT ahmadmovahedian detectionofduchennebeckermusculardystrophycarriersinagroupofiranianfamiliesbylinkageanalysis
AT majidghaffarpour detectionofduchennebeckermusculardystrophycarriersinagroupofiranianfamiliesbylinkageanalysis
AT gholamrezazamani detectionofduchennebeckermusculardystrophycarriersinagroupofiranianfamiliesbylinkageanalysis
AT hajifarajtabrizi detectionofduchennebeckermusculardystrophycarriersinagroupofiranianfamiliesbylinkageanalysis
AT mahdizamani detectionofduchennebeckermusculardystrophycarriersinagroupofiranianfamiliesbylinkageanalysis
_version_ 1724738145232093184